Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Health secretary Wes Streeting has backed the prescribing of the drugs to obese patients in the hope it can tackle the nation ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Although Novo will still make a mind-blowing amount of money from its existing obesity drugs in the coming years (its ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have taken drugs like Ozempic, Wegovy and Mounjaro. Demand for the drugs has ...

In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...

Health secretary Wes Streeting has backed the prescribing of the drugs to obese patients in the hope it can tackle the nation ...

Alzheimer's, addiction, cardiovascular diseases, kidney disorders, sleep apnoea, diabetes, obesity, and overweight.

Pharmacy benefit managers started popping up in the late 1960s as providers of claims processing and administrative services ...